Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Rhea-AI Summary

Enliven Therapeutics (Nasdaq: ELVN), a clinical-stage biopharmaceutical company specializing in small molecule therapeutics discovery and development, has announced its upcoming participation in the TD Cowen 45th Annual Health Care Conference. The company's management will engage in a fireside chat scheduled for Tuesday, March 4, 2025, at 10:30 a.m. ET.

The event will be accessible through a live webcast on the company's investor relations website at ir.enliventherapeutics.com. Interested parties who cannot attend the live session can access the archived recording, which will remain available for 90 days after the event's conclusion.

News Market Reaction – ELVN

+0.75%

1 alert

+0.75% News Effect

On the day this news was published, ELVN gained 0.75%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOULDER, Colo., Feb. 25, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025, at 10:30 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/. The webcast will be archived for a period of 90 days following the conclusion of the live event.

About Enliven Therapeutics
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in Boulder, Colorado.

View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-the-td-cowen-45th-annual-health-care-conference-302384762.html

SOURCE Enliven Therapeutics, Inc.

FAQ

When is Enliven Therapeutics (ELVN) presenting at the TD Cowen Healthcare Conference 2025?

Enliven Therapeutics will present on Tuesday, March 4, 2025, at 10:30 a.m. ET.

How can investors watch Enliven Therapeutics' (ELVN) TD Cowen conference presentation?

Investors can watch the presentation via live webcast on Enliven's investor relations website at ir.enliventherapeutics.com.

How long will Enliven Therapeutics' (ELVN) TD Cowen conference presentation be available for replay?

The webcast will be archived and available for 90 days following the live event.

What type of presentation will Enliven Therapeutics (ELVN) give at the TD Cowen conference?

Enliven Therapeutics' management will participate in a fireside chat format presentation.